The overexpression of CCL5 and/or its receptor CCR5 in various tumor cells (e.g. breast cancer,168 acute lymphocytic leukemia,169 multiple myeloma (MM),170 Hodgkin lymphoma,171 colorectal carcinoma172) has long been elucidated. Here, CCL5 is linked to breast carcinoma.